China Universal Asset Management Company’s Neurogene NGNE Stock Holding History

China Universal Asset Management Company’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.1K	Sell	2,515 -234	-9%	-$6.44K	﹤0.01%	436
2026 Q1	$55.4K	Buy	2,749 +225	+9%	+$4.36K	﹤0.01%	451
2025 Q4	$52K	Buy	2,524 +22	+0.9%	+$548	﹤0.01%	447
2025 Q3	$43.4K	Sell	2,502 -362	-13%	-$7.27K	﹤0.01%	441
2025 Q2	$42.8K	Sell	2,864 -116	-4%	-$1.82K	﹤0.01%	424
2025 Q1	$34.9K	Sell	2,980 -170	-5%	-$2.95K	﹤0.01%	440
2024 Q4	$72K	Buy	+3,150	New	+$117K	0.01%	423
2022 Q4	–	Sell	-20	Closed	–	–	433
2022 Q3	$0	Buy	+20	New	+$408	﹤0.01%	451

Other funds holding NGNE

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

RBI

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

China Universal Asset Management Company's NGNE Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Neurogene (NGNE) stake by 8.5% in Q2 2026, selling an estimated $6.44K and leaving 2,515 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

China Universal Asset Management Company first reported a position in NGNE in Q3 2022 and has held it in 8 quarters since. 22 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

China Universal Asset Management Company held 2,515 shares of Neurogene worth $79.1K as of Q2 2026.
China Universal Asset Management Company sold 234 Neurogene shares in Q2 2026, an estimated $6.44K.
Neurogene made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #436 holding.
China Universal Asset Management Company first reported a position in Neurogene in Q3 2022 and has held it in 8 quarters since.
22 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.